FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy – FDA.gov

June 21, 2023 by quixnet

FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular DystrophyFDA.gov
First Gene Therapy for Muscular Dystrophy ApprovedThe Wall Street Journal
Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular DystrophyBusiness Wire
Sarepta’s DMD gene therapy secures accelerated FDA approvalFiercePharma
FDA grants conditional approval to Sarepta’s gene therapy for Duchenne muscular dystrophySTAT